Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Ordinary Shares, nominal value of $0.01 per share
-
Shares outstanding
-
2,461,355,158
-
Total 13F shares
-
71,985
-
Share change
-
-158,648
-
Total reported value
-
$342,514
-
Price per share
-
$3.97
-
Number of holders
-
9
-
Value change
-
-$629,823
-
Number of buys
-
3
-
Number of sells
-
2
Institutional Holders of Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) as of Q2 2023
As of 30 Jun 2023 Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) had 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 71,985 shares of stock of the company.
Largest 9 holders included MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Activest Wealth Management, COMPASS GROUP LLC, JPMORGAN CHASE & CO, MORGAN STANLEY, CLEAR STREET LLC, and UBS Group AG.
This table shows 9 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.